Aufsatz(elektronisch)#129. November 2016
Iatrogene Hypersensitivitätsreaktion
In: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, Band 16, Heft 48
ISSN: 1424-4020
Suchergebnisse
Filter
2 Ergebnisse
Sortierung:
Verfügbarkeit an Ihrem Standort wird überprüft
Dieser Artikel ist auch in Ihrer Bibliothek verfügbar: |
elektronisch
gedruckt
Open Access#22019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions
Nicoletti, Paola; Barrett, Sarah; McEvoy, Laurence; Daly, Ann K; Aithal, Guruprasad; Lucena, M Isabel; Andrade, Raul J; Wadelius, Mia
Nicoletti, Paola; Barrett, Sarah; McEvoy, Laurence; Daly, Ann K; Aithal, Guruprasad; Lucena, M Isabel; Andrade, Raul J; Wadelius, Mia; Hallberg, Pär; Stephens, Camilla; Bjornsson, Einar S; Friedmann, Peter; Kainu, Kati; Laitinen, Tarja; Marson, Anthony; Molokhia, Mariam; Phillips, Elizabeth; Pichler, Werner; Romano, Antonino; Shear, Neil; Sills, Graeme; Tanno, Luciana K; Swale, Ashley; Floratos, Aris; Shen, Yufeng; Nelson, Matthew R; Watkins, Paul B; Daly, Mark J; Morris, Andrew P; Alfirevic, Ana; Pirmohamed, Munir
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download ; Carbamazepine (CBZ) causes life-threating T-cell-mediated hypersensitivity reactions, including serious cutaneous adverse reactions (SCARs) and drug-induced liver injury (CBZ-DILI). In order to evaluate shared or phenotype-specific genetic predisposing factors for CBZ hypersensitivity reactions, we performed a meta-analysis of two genomewide association studies (GWAS) on a total of 43 well-phenotyped Northern and Southern European CBZ-SCAR cases and 10,701 population controls and a GWAS on 12 CBZ-DILI cases and 8,438 ethnically matched population controls. HLA-A*31:01 was identified as the strongest genetic predisposing factor for both CBZ-SCAR (odds ratio (OR) = 8.0; 95% CI 4.10-15.80; P = 1.2 × 10-9 ) and CBZ-DILI (OR = 7.3; 95% CI 2.47-23.67; P = 0.0004) in European populations. The association with HLA-A*31:01 in patients with SCAR was mainly driven by hypersensitivity syndrome (OR = 12.9; P = 2.1 × 10-9 ) rather than by Stevens-Johnson syndrome/toxic epidermal necrolysis cases, which showed an association with HLA-B*57:01. We also identified a novel risk locus mapping to ALK only for CBZ-SCAR cases, which needs replication in additional cohorts and functional evaluation. ; European Union (EU) European Union (EU) Instituto de Salud Carlos III Medical Research Council UK (MRC) United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of Allergy & Infectious Diseases (NIAID) United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of General Medical Sciences (NIGMS) Swedish Heart-Lung Foundation Swedish Research Council MRC Centre for Drug Safety Science International Serious Adverse Events Consortium (iSAEC) National Institute for Health Research (NIHR) Nottingham Digestive Diseases Biomedical Research ...
BASE